Abpro Holdings (ABP)

• Market cap: $7.09M
• 1 day: -10%
• 5 days: -28.49%
• 1 month: -45.63%
• 3 months: -56.5%
• 6 months: -70.24%
• Year to date: -38.15%
• 1 year: -93.2%
• 5 years: -99.12%
• 10 years: -99.12%
• Sector: Healthcare
• Industry: Biotechnology

About: Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Employees: 6